European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Tenders

Oncology drug tenders in Lithuania

Oncology drug tenders in Lithuania: 196 listed on GranTender since 2024; 1 open now. The median awarded contract value is about €17,000 (54 contracts with a stated value). Buyers with the most tenders: Lietuvos sveikatos mokslų universiteto ligoninė Kauno klinikos (117), Valstybinė ligonių kasa prie Sveikatos apsaugos ministerijos (47) and Nacionalinis vėžio institutas (15); suppliers with the most contract awards: UAB "TAMRO" (39), Uždaroji akcinė bendrovė "ENTAFARMA" (34) and UAB "ARMILA" (30). Sources: CVP IS and TED. In 2025 the median contract value was €31,000. Data as of 18 November 2026; updated daily.

Tenders
196
Open tenders
1
Awards
204
Awarded value awarded
€3,785,490
Awarded value contract
€50,551,239
Median contract value contract
≈ €23,000
Median contract value awarded
≈ €17,000
Tenders in 2025
57 -48% on 2024

Median: contracts with a stated value, rounded. Average bids: contracts where the number of bids is published.

Value kinds: awarded — the value in the award decision; contract — the value of the signed or amended contract; paid — the amount actually paid; framework ceiling — the maximum of a framework agreement, given with every winner, not money spent. Different kinds are never added together.

Open tenders

Latest tenders

TenderBuyerEstimated valueStatusPublished
Vaistinis preparatas TrabektedinasLietuvos sveikatos mokslų universiteto ligoninė Kauno klinikos—Awarded3 November 2026
Monokloniniai antikūnai metastazavusiam gaubtinės arba tiesiosios žarnos vėžiui gydyti (Cetuximab ir (ar) Panitumumab)Valstybinė ligonių kasa prie Sveikatos apsaugos ministerijos—Open2 November 2026
Vaistinis preparatas TrabektedinasLietuvos sveikatos mokslų universiteto ligoninė Kauno klinikos—Awarded16 October 2026
581115 DPS "Vaistiniai preparatai", konkretus pirkimas "Vaistiniai preparatai" (pirkimo Nr. 8311459)Lietuvos sveikatos mokslų universiteto ligoninė Kauno klinikos—Awarded2 September 2026
Medikamentas EkulizumabasLietuvos sveikatos mokslų universiteto ligoninė Kauno klinikos—Awarded17 August 2026
Pirkimo sutartis, medikamentas EkulizumabasLietuvos sveikatos mokslų universiteto ligoninė Kauno klinikos—Awarded27 July 2026
Vaistinis preparatas AlemtuzumabValstybinė ligonių kasa prie Sveikatos apsaugos ministerijos—Awarded16 June 2026
Medikamentas SatralizumabasLietuvos sveikatos mokslų universiteto ligoninė Kauno klinikos—Awarded15 June 2026
Vaistinis preparatas RamucirumabValstybinė ligonių kasa prie Sveikatos apsaugos ministerijos—Awarded26 May 2026
Vaistinis preparatas Daunorubicinas su citarabinuValstybinė ligonių kasa prie Sveikatos apsaugos ministerijos—Awarded23 April 2026
Vaistinis preparatas Pegiliuotas doksorubicinasValstybinė ligonių kasa prie Sveikatos apsaugos ministerijos—Awarded8 April 2026
Vaistinis preparatas BevacizumabValstybinė ligonių kasa prie Sveikatos apsaugos ministerijos—Awarded17 March 2026
Vaistinis preparatas MidostaurinValstybinė ligonių kasa prie Sveikatos apsaugos ministerijos—Awarded6 March 2026
Vaistinis preparatas TrabektedinasLietuvos sveikatos mokslų universiteto ligoninė Kauno klinikos—Awarded3 March 2026
Vaistinis preparatas BevacizumabValstybinė ligonių kasa prie Sveikatos apsaugos ministerijos—Awarded19 January 2026
Vaistinis preparatas BevacizumabValstybinė ligonių kasa prie Sveikatos apsaugos ministerijos—Awarded19 January 2026
Monokloniniai antikūnai metastazavusiam gaubtinės arba tiesiosios žarnos vėžiui gydyti (Cetuximab ir/arba Panitumumab)Valstybinė ligonių kasa prie Sveikatos apsaugos ministerijos—Awarded12 January 2026
Vaistinis preparatas TeklistamabasValstybinė ligonių kasa prie Sveikatos apsaugos ministerijos—Awarded10 December 2025
Vaistinis preparatas RamucirumabValstybinė ligonių kasa prie Sveikatos apsaugos ministerijos—Awarded9 December 2025
Pirkimo-pardavimo sutartis, mikrosferos kepenų navikinių darinių radioembolizacijaiLietuvos sveikatos mokslų universiteto ligoninė Kauno klinikos—Awarded29 October 2025

Competition and prices

In 2025, half of the contracts were worth between €6,900 and €270,000, with a median of €31,000 (41 contracts with a stated contract value). Compared with 2024, in 2025 the median value rose 121%. The usual procedures: restricted procedure (61%), negotiation without a call for competition (26%), open procedure (13%) — of 46 tenders with a stated procedure.

The most contracts went to UAB "TAMRO" (39), Uždaroji akcinė bendrovė "ENTAFARMA" (34) and UAB "ARMILA" (30) — together 50% of all contracts.

YearContractsMedian valueMiddle half of valuesBids on averageSingle bid
2024117€14,000 (contract value)€2,300 – €97,000——
202555€31,000 (contract value)€6,900 – €270,000——
2026 (so far)32€41,000 (contract value)€10,000 – €520,000——
All years204€23,000 (contract value)€2,600 – €220,000——

Values: contracts with a stated value in EUR, each value kind on its own (awarded or contract value), approximate (±3 %). Bids: contracts of procedures with competition whose number of bids the source publishes (1–100 bids); the sources publish it for some contracts only (TED ≈ 3 in 4, Spain all, Poland about half, Italy few), so each figure states its base and is shown from 20 contracts. A contract counts in the year of its award (else of its tender). Figures as of 13 November 2026, recomputed every week.

Where you have a chance

In the last 12 months, 0 companies won their first contract in our records here — 0% of the 32 contracts (our records start on 1 January 2024).

Contracts awarded since 1 November 2024 (the last 24 months). Bids as the source publishes them, 1 to 100 per contract, in procedures with competition only (a direct award has one offer by design). As of 13 November 2026.

Main CPV divisions

CPV codes of this topic

  • 33652000 Antineoplastic and immunomodulating agents

A tender belongs here when its main CPV code starts with one of these codes; a tender without a usable CPV code (or with a general one) is matched by words of its title. A tender may belong to up to three topics.

Oncology and immunomodulating drugs in neighbouring countries

Today, 16 tenders in the same niche are open in neighbouring countries.

Public tenders in the EU and the EEA are open to companies from every EU and EEA country on the same terms as local ones, and to companies from countries with a procurement agreement with the EU (such as Switzerland, the United Kingdom and Ukraine) for the contracts it covers. Open means the deadline has not passed (today's date). Neighbours: countries with a land border, a fixed link or a short sea crossing.

Market reports

Oncology and immunomodulating drugs by city

Oncology and immunomodulating drugs in other countries

Oncology and immunomodulating drugs across Europe

Topics in Health, medical equipment and medicines

Questions and answers

Which oncology drug tenders in Lithuania are open now?
1 of the 196 oncology drug tenders in Lithuania listed on GranTender is open for bids. For example: Monokloniniai antikūnai metastazavusiam gaubtinės arba tiesiosios žarnos vėžiui gydyti (Cetuximab ir (ar) Pan….
Where can I find oncology drug tenders in Lithuania?
GranTender lists them in one place, from CVP IS and TED, with their buyers, winners and contract values; 1 is open now. Search in one country at a time (the first 5 results) is free; search across all countries at once, full result lists, saved keywords with an e-mail once a week and exports come with a plan.
Who wins the most oncology drug tenders in Lithuania?
By number of contracts won: UAB "TAMRO" (39), Uždaroji akcinė bendrovė "ENTAFARMA" (34), UAB "ARMILA" (30).
Which buyers publish the most oncology drug tenders in Lithuania?
By number of tenders: Lietuvos sveikatos mokslų universiteto ligoninė Kauno klinikos (117), Valstybinė ligonių kasa prie Sveikatos apsaugos ministerijos (47), Nacionalinis vėžio institutas (15).
Which CPV codes belong to “Oncology and immunomodulating drugs”?
33652000 Antineoplastic and immunomodulating agents; plus tenders without a usable CPV code whose title names the topic.
How much are contracts for oncology drug tenders in Lithuania worth?
In 2025, half of the contracts were worth between €6,900 and €270,000, with a median of €31,000 (41 contracts with a stated contract value). Compared with 2024, in 2025 the median value rose 121%.
Which procedures are used for oncology drug tenders in Lithuania?
The usual procedures: restricted procedure (61%), negotiation without a call for competition (26%), open procedure (13%) — of 46 tenders with a stated procedure.

CPV 2008 (Regulation (EC) No 213/2008), © European Union, Publications Office — via the eForms SDK, CC BY 4.0.